SCHEMBL7339274

SCHEMBL7339274

C[C@@H](C(N)=O)N(C(=O)[C@H](Cc1ccccc1)NS(=O)(=O)N1CC[N+](C)([O-])CC1)c1cc[nH]n1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.34
CA12 O43570 2/20 0.33
CA9 Q16790 2/20 0.33
CA2 P00918 1/20 0.33
CA7 P43166 1/20 0.33
CA14 Q9ULX7 1/20 0.33
REN P00797 6/20 0.33
PLG P00747 3/20 0.32
F12 P00748 1/20 0.32
PLAU P00749 1/20 0.32
KLKB1 P03952 1/20 0.32
PROC P04070 1/20 0.32
HPN P05981 1/20 0.32
F10 P00742 1/20 0.32
AVPR1A P37288 1/20 0.32
F2 P00734 2/20 0.32
GAA P10253 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2C19 P33261 1/20 0.32
CA1 P00915 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7337437 0.88 AVPR1A (0.40) TSHRRENPLGPLAUAVPR1A
SCHEMBL7332211 0.88 REN (0.39) TSHRCA12CA9CA2CA7
SCHEMBL7338390 0.88 REN (0.42) REN
SCHEMBL7329392 0.86 REN (0.38) TSHRCA12CA9CA2CA7
SCHEMBL7328871 0.85 AVPR1A (0.38) TSHRRENPLGPLAUAVPR1A
SCHEMBL7338647 0.85 CTSS (0.33)
SCHEMBL7338102 0.83 F2 (0.34) TSHRCA12CA9CA2CA7
SCHEMBL7341341 0.83 ALDH1A1 (0.36) TSHRRENF10
SCHEMBL7333972 0.83 TSHR (0.35) TSHRRENPLGF12PLAU
SCHEMBL7338971 0.79 TSHR (0.34) TSHRCA12CA9CA2CA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5310740-A Congestive heart failure, hypotensive agents, antiglaucoma agents; side effect reduction ABBOTT LABORATORIES (US) 1994-05-10 US disclosed
US-5284849-A Treating hypertension and congestive heart failure ABBOTT LABORATORIES (US) 1994-02-08 US disclosed
EP-0456185-A2 Renin inhibitors ABBOTT LABORATORIES (US) 1991-11-13 EP disclosed